CORC

浏览/检索结果: 共13条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL ACTIVE-CONTROLLED CLINICAL TRIAL COMPARING PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY AND EXPLORATORY EFFICACY BETWEEN HLX01 AND EUROPE-SOURCED RITUXIMAB AS A NEW INDICATION IN CHINESE MODERATE TO 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Zeng, Xiaofeng;  Wang, Yongfu;  Jiang, Zhenyu;  Zhang, Zhuoli;  He, Lan
收藏  |  浏览/下载:45/0  |  提交时间:2020/01/03
EFFICACY, PHARMACOKINETICS, SAFETY AND IMMUNOGENICITY OF THE BIOSIMILAR HS016 IN COMPARISON WITH ADALIMUMAB IN CHINESE PATIENTS WITH ANKYLOSING SPONDYLITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PHASE 3 TRIAL 会议论文
ANNALS OF THE RHEUMATIC DISEASES, 2019-06-01
作者:  Su, Jinmei;  Li Mengtao;  Zeng, Xiaofeng
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Safety, Pharmacokinetics and Dosimetry of a Long-lasting Radiolabeled Somatostatin Analogue Lu-177-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors: A Phase 1 First-in-human Study 会议论文
JOURNAL OF NUCLEAR MEDICINE, 2018-05-01
作者:  Zhang, Jingjing;  Niu, Gang;  Wang, Hao;  Jacobson, Orit;  Cheng, Yuejuan
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/03
Phase ib study of safety, tolerability and pharmacokinetics of simotinib in patients with advanced non-small cell lung cancer 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Hu, Xingsheng;  Han, Xiaohong;  Zhang, Li;  Ding, Yanhua;  Wang, Hanping
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/04
CHARACTERIZATION OF THE PHARMACOKINETICS OF IXAZOMIB IN CHINESE PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA IN THE CHINA CONTINUATION OF THE TOURMALINE-MM1 STUDY. 会议论文
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017-02-01
作者:  Hanley, M. J.;  Gupta, N.;  Hou, J.;  Xu, Y.;  Jin, J.
收藏  |  浏览/下载:4/0  |  提交时间:2020/01/04
Phase I study of safety and pharmacokinetics for CT-707 in ALK-positive advanced non-small cell lung cancer 会议论文
ANNALS OF ONCOLOGY, 2017-11-01
作者:  Shi, Y-K.;  Hao, X. Z.;  Xing, P.;  Hu, B.;  Sun, Y.
收藏  |  浏览/下载:3/0  |  提交时间:2020/01/04
Pharmacokinetics of Bendamustine Hydrochloride in Chinese Patients with Indolent Non-Hodgkin Lymphoma (iNHL) Refractory to Rituximab Treatment 会议论文
BLOOD, 2016-12-02
作者:  Han, Xiaohong;  Li, Ning;  Song, Yuan-Yuan;  Hellriegel, Edward;  Robertson, Philmore
收藏  |  浏览/下载:11/0  |  提交时间:2020/01/04
A phase I study for tolerability, safety, and pharmacokinetics of pyrotinib, a novel irreversible HER2 and EGFR inhibitor, in Chinese patients with HER2(+) metastatic breast cancer. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2015-05-20
作者:  Xu, Binghe;  Ma, Fei;  Chen, Shanshan;  Li, Qiao;  Yang, Fan
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/04
Phase I clinical pharmacokinetics, safety and tolerability of simotinib in advanced NSCLC patients with EGFR mutation 会议论文
EUROPEAN JOURNAL OF CANCER, 2015-09-01
作者:  Han, X.;  Li, N.;  Hu, X.;  Song, Y.;  Zhang, Y.
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/04
PHARMACOKINETICS, PHARMACODYNAMICS, SAFETY, AND EFFICACY STUDY OF PLERIXAFOR IN CHINESE PATIENTS WITH NON-HODGKIN LYMPHOMA (NHL) 会议论文
HAEMATOLOGICA, 2015-06-01
作者:  Zhu, J.;  Chen, H.;  Li, Z.;  Hu, J.;  Li, J.
收藏  |  浏览/下载:6/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace